Oral Cancer Treatment Market - Top Companies and Manufacturers

Companies Dominating the Oral Cancer Treatment Landscape

The current dynamics of the oral cancer treatment market are changing due to the integration of advanced technologies such as AI and cloud-based platforms. These are increasing the effectiveness of available treatments and therapies for the patients. For instance, in March 2023, IJNRD released a research paper on the usage of artificial intelligence in oral medical oncology and CDSS. The journal further states that chatbots and virtual assistants can help clinical professionals suggest the most effective treatment options. Such innovations are encouraging global leaders to expand their reach by introducing new therapeutics. Such key players in the market include:

Bristol-Myers Squibb Company
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
Qilu Pharmaceutical Co., Ltd.
Teva Pharmaceutical Industries Ltd.
Eli Lilly and Company.
F Hoffmann-La Roche Ltd
Merck & Co., Inc.
Novartis AG
Pfizer Inc.
Jaguar Health
VELscope

Browse Key Market Insights with Data Illustration:

Oral Cancer Treatment Market Size, Forecast Report 2037

In the News

In October 2024, Jaguar launched the FDA-approved oral mucositis prescription product, Gelclair to commercialize it in the U.S. market. The product can offer significant relief to mouth inflammation, adverse of oncology treatments.
In January 2024, VELscope collaborated with OralMedicine.com to launch a clinical decision support service to assist dental professionals in oral cancer screening and mucosal disease management. The support system is powered by ahVanguard healthcare consultants to assist all VELscope users.

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of the oral cancer treatment market was over USD 2.2 billion.

The market size for the oral cancer treatment market is projected to reach USD 4.7 billion by the end of 2037 expanding at a CAGR of 6.7% during the forecast period i.e., between 2025-2037.

The major players in the market are Bristol-Myers Squibb Company, Qilu Pharmaceutical Co., Ltd., Teva Pharmaceutical Industries Ltd., Eli Lilly and Company., F Hoffmann-La Roche Ltd, Merck & Co., Inc., Novartis AG, Pfizer Inc., and others.

In terms of applications, the hospitals and clinics segment is anticipated to garner the largest market share of 57.4% by 2037 and display lucrative growth opportunities during 2025-2037.

The market in North America is projected to hold the largest market share of 51.0% by the end of 2037 and provide more business opportunities in the future.

Oral Cancer Treatment Market - Top Companies and Manufacturers

Companies Dominating the Oral Cancer Treatment Landscape

Browse Key Market Insights with Data Illustration:

In the News

Frequently Asked Questions (FAQ)

How big is the oral cancer treatment market?

What is the outlook for the oral cancer treatment market?

Who are the major players dominating the oral cancer treatment market?

Which application segment will capture the significant market share for the oral cancer treatment market by 2037?

Which region will provide more business opportunities for the growth of the oral cancer treatment market in the future?